23 May 2022 , 11:33 AM
Result date: 25th May, 2022
Recommendation: Buy
Target price: Rs5,400
Apollo Hospitals Enterprise (Apollo) could post 68% bed occupancy rates for the March 2022 quarter. With volumes of inpatient and outpatient segments growing 17% and 20%, respectively over the year-ago quarter; average revenue per occupied bed (ARPOB) could improve 10%. Pharma and hospital business could post robust revenue growth, taking overall growth in topline to 28%.
The Company’s EBITDA margin could inch up 84 basis points over the year-ago quarter. However, sequentially, this metric could decline 93 basis points to 15.2% amid lower non-COVID occupancies following the third wave of the pandemic.
Profit After Tax (PAT) could surge 46% over the year-ago quarter.
Important management insights to watch out for:
· Growth outlook across all business segments
· Breakeven of 24x7
· Margin drivers in the future
Rs Million | March 2022 estimates | YoY change | QoQ change |
Revenue | 36,715 | 28% | 1% |
EBITDA | 5,581 | 36% | (5)% |
Profit After Tax | 2,089 | 46% | (9)% |
Source: IIFL Research
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.